An interventional study of Hypnosis, kinesitherapy, MEOPA and Usual practice in Algodystrophy of Hand, sponsored by University Hospital, Toulouse. Completed at 2 sites in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2023-08-23.
Sponsored by University Hospital, Toulouse · Not applicable, Interventional, and Supportive care
Relation between hypnosis and MEOPA on algodystrophy.
43 studies on the registry are indexed under Reflex Sympathetic Dystrophy; 4 are open to participants now.
This study's enrollment of 62 is above the median of 48 across 35 interventional studies indexed under Reflex Sympathetic Dystrophy.
Browse Reflex Sympathetic Dystrophy studies →University Hospital, Toulouse is the lead sponsor of 807 studies on the registry; 209 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
combined therapy of Hypnosis Kinesitherapy and MEOPA (HKM)
Other: Hypnosis, kinesitherapy, MEOPA
physiopathology and treatments
Other: Usual practice
classical intervention
Also known as: Hypnosis Kinesitherapy and MEOPA (HKM)
Usual practice with treatments and physio
Pain intensity measure using visual analogical ladder (EVA)
pain intensity is determined by patient himself on a visual analogical ladder created by Huskisson
Time frame: 3 weeks
QDSA ( Saint Antoine Pain Questions)
description of the type of pain
Time frame: 3 weeks
SF36 (Short Form (36) Health Survey)
quality of life appreciation
Time frame: 3 weeks
HADs
Hospital Anxiety and Depression Scale
Time frame: 3 weeks
Plan to share: No
This study is completed, as verified in Aug 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Reflex Sympathetic Dystrophy →
University Hospital, Toulouse →